logo Click here for the Chao Family Comprehensive Cancer Center Home Page Click here for the UC Irvine Home Page
 
 
 
 

Southern California Chemoprevention Consortium Trial Listing

Home     About Us     About Clinical Trials     Participating Organizations     Study Coordinator Site    

SCCC Trials in Development

To be announced soon

Closed SCCC Trials

  • UCI 03-1-01 "A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial Of Lovastatin for Various Endpoints of Melanoma Pathobiology" (Publication under development)
  • UCI 04-3-01 "A Phase II, Randomized, Controlled Trial of The Safety And Efficacy Of S-Adenosyl-L-Methionine Disulphate P-Toluene-Sulfonate (SAMe) In Reducing Serum Alpha-Fetoprotein (AFP) In Patients With Hepatitis C And Moderately Elevated AFP" (Publication under development)
  • UCI06-8-01 "A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting EGF Receptor Signaling in Aberrant Crypt Foci of the Colon" (contact 714-456-3669 for more information)
  • UCI09-13-01 "A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Patients with a History of Colorectal Adenomas and Elevated Body Mass Index" (contact 714-456-6210 for more information)

Completed SCCC Trials

  • UCI04-2-01 "A Phase IIA Trial of Curcumin Among Patients with Prevalent Subclinical Neoplastic Lesions" (Aberrant Crypt Foci)
  • UCI05-5-01 "Phase IIA Trial Testing Erlotinib as an Intervention Against Intraductal Pancreatic Mucinous Neoplasms"

SCCC Administrative Office

101  The City Drive South
Bldg 56
Orange, CA 92868
Phone: 888-456-7067
FAX: 714-456-7031
Email: SCCC.ASSIST@uci.edu
www.cancer.uci.edu

spacer